Lubawa S.A. (WSE:LBW)

Theseus Pharmaceuticals Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	43.45	162.66	96.8	10.21	8.14	11.54
Short-Term Investments	127.97	77.91	1.42	1.21	1.6	1.55
Cash & Short-Term Investments	171.41	240.57	98.23	11.41	9.74	13.09
Cash Growth	164.16%	144.91%	760.67%	17.22%	-25.63%	22.55%
Accounts Receivable	159.35	89.4	87.54	66.68	80.67	80.19
Other Receivables	-	56.15	17.51	12.37	17.14	11.61
Receivables	159.36	145.56	106.47	79.05	98.41	92.42
Inventory	131.69	113.02	103.57	91.95	91.59	72.71
Other Current Assets	1.18	0.61	1.97	0.86	0.05	0.05
Total Current Assets	463.64	499.76	310.23	183.27	199.78	178.27
Property, Plant & Equipment	186.98	187.87	178.37	176.31	169.77	170.89
Long-Term Investments	1.8	1.82	1.91	1.96	2.29	2.62
Other Intangible Assets	62.38	49.82	52.12	49.59	46.4	48.94
Long-Term Deferred Charges	-	12.68	10.04	10.91	12.37	9.41
Other Long-Term Assets	4.43	4.28	7.63	1.71	1.71	8.77
Total Assets	719.81	756.87	560.3	424.4	432.33	418.9
Accounts Payable	198.18	41.53	43.91	28.03	45.81	43.38
Accrued Expenses	10.01	51.16	28.92	10.52	14.89	10.68
Current Portion of Long-Term Debt	-	0.01	4.83	21.41	11.04	36.37
Current Portion of Leases	1.12	1.14	1.32	1.39	0.76	1.07
Current Income Taxes Payable	0.17	10.21	3.04	0.57	2.19	6.02
Current Unearned Revenue	-	2.23	4.29	1.77	2.32	1.93
Other Current Liabilities	6.09	158.38	72.59	4.85	18.45	2.85
Total Current Liabilities	215.57	264.66	158.89	68.54	95.45	102.3
Long-Term Debt	-	-	6.92	10.14	13.36	16.71
Long-Term Leases	2.54	2.89	4.1	2.53	1.59	2.21
Long-Term Unearned Revenue	10.06	10.32	9.7	9.85	10.43	9.42
Long-Term Deferred Tax Liabilities	15.13	14.69	16.46	15.63	15.63	16.18
Total Liabilities	244.8	294.06	197.36	107.48	137.26	147.56
Common Stock	30.05	30.05	30.05	30.05	30.05	30.05
Additional Paid-In Capital	106.1	106.1	106.1	106.1	106.1	106.1
Retained Earnings	334.44	322.82	222.03	176.95	156.34	132.1
Comprehensive Income & Other	3.59	2.96	3.82	2.67	1.68	2.1
Total Common Equity	474.18	461.94	362	315.77	294.17	270.36
Minority Interest	0.83	0.87	0.94	1.15	0.9	0.98
Shareholders' Equity	475.01	462.81	362.94	316.91	295.07	271.34
Total Liabilities & Equity	719.81	756.87	560.3	424.4	432.33	418.9
Total Debt	3.66	4.04	17.17	35.47	26.75	56.36
Net Cash (Debt)	167.75	236.53	81.06	-24.06	-17.01	-43.26
Net Cash Growth	232.89%	191.79%	-	-	-	-
Net Cash Per Share	1.12	1.57	0.54	-0.16	-0.11	-0.29
Filing Date Shares Outstanding	150.27	150.27	150.27	150.27	150.27	150.27
Total Common Shares Outstanding	150.27	150.27	150.27	150.27	150.27	150.27
Working Capital	248.08	235.11	151.34	114.74	104.33	75.96
Book Value Per Share	3.16	3.07	2.41	2.10	1.96	1.80
Tangible Book Value	411.81	412.12	309.88	266.18	247.77	221.42
Tangible Book Value Per Share	2.74	2.74	2.06	1.77	1.65	1.47
Land	-	12.22	12.21	12.21	12.12	12.13
Buildings	-	122.8	120.81	119.23	116.01	115.46
Machinery	-	149	130.47	123.15	116.57	111.16
Construction In Progress	-	10.8	11.88	11.98	6.07	3.64

Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.